Ethos AI-Powered Radiotherapy System Follows Movement of Tumors

Varian has won FDA clearance for its Ethos therapy technology, which the company describes as an Adaptive Intelligence solution for improved tumor targeting during radiotherapy.

Adaptive therapy allows clinicians to target tumors based on imaging performed during treatment sessions. This is important, as the internal anatomy tends to shift (Read more...)

Full Story →